Authors: Schooley, RT Spino, C Kuritzkes, D Walker, BD Valentine, FT Hirsch, MS Cooney, E Friedland, G Kundu, S Merigan, TC McElrath, MJ Collier, A Plaeger, S Mitsuyasu, R Kahn, J Haslett, P Uherova, P deGruttola, V Chiu, S Zhang, B Jones, G Bell, D Ketter, N Twadell, T Chernoff, D Rosandich, M

Citation: Rt. Schooley et al., Two double-blinded, randomized, comparative trials of 4 human immunodeficiency virus type 1 (HIV-1) envelope vaccines in HIV-1-infected individuals across a spectrum of disease severity: AIDS clinical trials groups 209 and 214, J INFEC DIS, 182(5), 2000, pp. 1357-1364

Authors: Bekker, LG Haslett, P Maartens, G Steyn, L Kaplan, G

Citation: Lg. Bekker et al., Thalidomide-induced antigen-specific immune stimulation in patients with human immunodeficiency virus type 1 and tuberculosis. (vol 181, pg 954, 2000), J INFEC DIS, 181(4), 2000, pp. 1521-1521

Authors: Bekker, LG Haslett, P Maartens, G Steyn, L Kaplan, G

Citation: Lg. Bekker et al., Thalidomide-induced antigen-specific immune stimulation in patients with human immunodeficiency virus type 1 and tuberculosis, J INFEC DIS, 181(3), 2000, pp. 954-965

Authors: Granelli-Piperno, A Zhong, L Haslett, P Jacobson, J Steinman, RM

Citation: A. Granelli-piperno et al., Dendritic cells, infected with vesicular stomatitis virus-pseudotyped HIV-1, present viral antigens to CD4(+) and CD8(+) T cells from HIV-1-infected individuals, J IMMUNOL, 165(11), 2000, pp. 6620-6626